CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Dante Genomics has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Next Generation Sequencing Solutions Companies – 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Andrea Riposati , CEO and Mattia Capulli CSO.

Dante Genomics
Making Genome Sequencing Tests Accessible to All

Dante Genomics

Andrea Riposati CEO and Mattia Capulli CSO, Dante Genomics | Life Science Review | Top Next Generation Sequencing Solutions CompaniesAndrea Riposati CEO and Mattia Capulli CSO
Whole genome sequencing (WGS) is an ideal choice for researchers and healthcare professionals for testing genetic disorders due to its ability to detect various disease-causing genetic variants in a single test by sequencing the entire protein-coding and non-coding regions of the genome. However, despite its potential, WGS is not easily accessible and is not a gold standard yet.

Dante Genomics, a leading global genomics and precision medicine company, aims to bridge this inaccessibility gap and make WGS accessible to everyone. The company leverages WGS technology and variant interpretation to help consumers and healthcare specialists make informed decisions about their/patient’s health.

“We make whole genome sequencing tests accessible and affordable to everyone,” says Francesco Pennelli, senior director of marketing, Dante Genomics.

Dante Genomics has numerous sequencing centers worldwide in Europe, the U.S., and the United Arab Emirates that use highly advanced genomics software, Avanti, to interpret the data from genome sequencing tests. The intuitive web-based DNA raw data analysis platform can analyze hundreds of gigabytes of genomic data and transform it into insightful and actionable reports within minutes. Avanti generates more than 100 reports daily, from clinical panels to nutrition and fitness reporting.

Healthcare specialists can easily sign up to Avanti by entering their email address and password to transform next-generation sequencing (NGS) raw data into insightful and clear reports. Without downloading or deploying any software into their systems, practitioners—with an easy login to a web-based app—can upload raw DNA data and obtain reports per their patient’s needs.

Avanti’s pricing model is also straightforward. Practitioners can pay per analysis without any upfront costs, subscriptions, or cancellation fees.

Individuals who wish to have their genome sequenced to make better health decisions can purchase tests online with no shipping cost. They can collect their blood sample in an easy, painless, and aseptic way with Dante Genomics’ straightforward explanatory video. Once it receives samples, the company provides individuals with easily comprehensible reports within a few weeks, which are accessible to them throughout their life. In other words, customers sequence their genomes once in their life and have genomic data available at any time.

We make whole genome sequencing tests accessible and affordable to everyone

Individuals can also share these reports with their doctor and receive an expert opinion about their health condition. These reports help them understand how the person is predisposed to develop any condition or disease, allowing individuals to act accordingly in their daily life to prevent this development. For example, a cardiologist got his genome sequenced and found his lipid profile (cholesterol in his blood result) is the mutation he inherited from his parents. This helped him make the necessary changes in his dietary habits to stay fit.

The genomic data by Dante Genomics provides doctors with a unique tool and the information to treat and prevent some deadly diseases in the best way possible. The company continually makes efforts to engage more people and spread awareness about the benefits of genome sequencing tests. Dante Genomics believes genome sequencing tests will be the gold standard within the genomic industry in the coming years and continues to work toward making WGS technology accessible to all.

Top 10 Next Generation Sequencing Solutions Companies – 2023
Current Issue

Company : Dante Genomics

Management
Andrea Riposati CEO and Mattia Capulli CSO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/dante-genomics